Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd Announces Launch Of Montelukast Sodium Oral Granules


Thursday, 27 Sep 2012 03:02am EDT 

Dr.Reddy's Laboratories Ltd announced that it has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (montelukast sodium) oral granules in the US market on September 26, 2012 following the approval by the USFDA of Dr.Reddy's ANDA for Montelukast Sodium Oral Granules . 

Company Quote

2816.9
-21.6 -0.76%
5:59am EDT